Literature DB >> 7044118

Effect of antibiotics on the immune response.

W E Hauser, J S Remington.   

Abstract

Mesh:

Substances:

Year:  1982        PMID: 7044118     DOI: 10.1016/0002-9343(82)90534-4

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  37 in total

Review 1.  Interference of antibacterial agents with phagocyte functions: immunomodulation or "immuno-fairy tales"?

Authors:  M T Labro
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

2.  The "infection equation".

Authors:  S Ringoir
Journal:  Infection       Date:  1992       Impact factor: 3.553

3.  Subinhibitory antimicrobial concentrations: A review of in vitro and in vivo data.

Authors:  G G Zhanel; D J Hoban; G K Harding
Journal:  Can J Infect Dis       Date:  1992-07

4.  Aryl-fluoroquinolone derivatives A-56619 (difloxacin) and A-56620 inhibit mitogen-induced human mononuclear cell proliferation.

Authors:  S V Gollapudi; B Vayuvegula; S Gupta; M Fok; H Thadepalli
Journal:  Antimicrob Agents Chemother       Date:  1986-09       Impact factor: 5.191

Review 5.  Immunological aspects of new quinolones.

Authors:  I Shalit
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267

6.  Therapeutic effect of clarithromycin on a transplanted tumor in rats.

Authors:  K Sassa; Y Mizushima; T Fujishita; R Oosaki; M Kobayashi
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

Review 7.  Immunomodulation by antibacterial agents. Is it clinically relevant?

Authors:  M T Labro
Journal:  Drugs       Date:  1993-03       Impact factor: 9.546

8.  Effects of naftifine and terbinafine, two allylamine antifungal drugs, on selected functions of human polymorphonuclear leukocytes.

Authors:  T Vago; G Baldi; D Colombo; M Barbareschi; G Norbiato; F Dallegri; M Bevilacqua
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191

9.  Cefodizime: enhancement of depressed phagocytosis-associated respiratory burst activity in chronic uremic patients.

Authors:  R Vanholder; S Ringoir
Journal:  Infection       Date:  1992       Impact factor: 3.553

10.  A prospective multi-center trial of Escherichia coli extract for the prophylactic treatment of patients with chronically recurrent cystitis.

Authors:  Kun Suk Kim; Ji-Yoon Kim; In Gab Jeong; Jae-Seung Paick; Hwancheol Son; Dae Jung Lim; Hong Bang Shim; Won Hee Park; Hee Chang Jung; Myung-Soo Choo
Journal:  J Korean Med Sci       Date:  2010-02-17       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.